Tweet
PLoS One
. 2024 Mar 27;19(3):e0287068.
doi: 10.1371/journal.pone.0287068. eCollection 2024. Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses
Sayaka Nagasawa 1 , Yuichiro Hirata 1 2 , Sho Miyamoto 2 , Seiya Ozono 2 , Shun Iida 2 , Harutaka Katano 2 , Shigeki Tsuneya 1 3 , Kei Kira 3 , Susumu Kobayashi 3 , Makoto Nakajima 3 , Hiroyuki Abe 4 , Masako Ikemura 4 , Isao Yamamoto 5 6 , Kimiko Nakagawa 5 6 , Kazumi Kubota 7 , Shinji Akitomi 8 9 , Iwao Hasegawa 5 6 , Tetsuo Ushiku 4 , Tadaki Suzuki 2 , Hirotaro Iwase 1 3 , Yohsuke Makino 1 3 , Hisako Saitoh 1 10
Affiliations
High viral titers of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been detected in human corpses long after death. However, little is known about the kinetics of infectious SARS-CoV-2 in corpses. In this case series study, we investigated the postmortem kinetics of infectious SARS-CoV-2 in human corpses by collecting nasopharyngeal swab samples at multiple time points from six SARS-CoV-2-infected patients after their death. SARS-CoV-2 RNA was detected by quantitative reverse transcription-polymerase chain reaction from nasopharyngeal swab samples collected from all six deceased patients. A viral culture showed the presence of infectious virus in one deceased patient up to 12 days after death. Notably, this patient had a shorter time from symptom onset to death than the other patients, and autopsy samples showed pathological findings consistent with viral replication in the upper respiratory tract. Therefore, this patient died during the viral shedding phase, and the amount of infectious virus in the corpse did not decrease over time up to the date of autopsy (12 days after death). The findings of this study indicate that the persistence of SARS-CoV-2 in corpses can vary among individuals and may be associated with the stage of the disease at the time of death. These important results complement many previously reported findings on the infectivity of SARS-CoV-2 at postmortem.
. 2024 Mar 27;19(3):e0287068.
doi: 10.1371/journal.pone.0287068. eCollection 2024. Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses
Sayaka Nagasawa 1 , Yuichiro Hirata 1 2 , Sho Miyamoto 2 , Seiya Ozono 2 , Shun Iida 2 , Harutaka Katano 2 , Shigeki Tsuneya 1 3 , Kei Kira 3 , Susumu Kobayashi 3 , Makoto Nakajima 3 , Hiroyuki Abe 4 , Masako Ikemura 4 , Isao Yamamoto 5 6 , Kimiko Nakagawa 5 6 , Kazumi Kubota 7 , Shinji Akitomi 8 9 , Iwao Hasegawa 5 6 , Tetsuo Ushiku 4 , Tadaki Suzuki 2 , Hirotaro Iwase 1 3 , Yohsuke Makino 1 3 , Hisako Saitoh 1 10
Affiliations
- PMID: 38536820
- PMCID: PMC10971691
- DOI: 10.1371/journal.pone.0287068
High viral titers of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been detected in human corpses long after death. However, little is known about the kinetics of infectious SARS-CoV-2 in corpses. In this case series study, we investigated the postmortem kinetics of infectious SARS-CoV-2 in human corpses by collecting nasopharyngeal swab samples at multiple time points from six SARS-CoV-2-infected patients after their death. SARS-CoV-2 RNA was detected by quantitative reverse transcription-polymerase chain reaction from nasopharyngeal swab samples collected from all six deceased patients. A viral culture showed the presence of infectious virus in one deceased patient up to 12 days after death. Notably, this patient had a shorter time from symptom onset to death than the other patients, and autopsy samples showed pathological findings consistent with viral replication in the upper respiratory tract. Therefore, this patient died during the viral shedding phase, and the amount of infectious virus in the corpse did not decrease over time up to the date of autopsy (12 days after death). The findings of this study indicate that the persistence of SARS-CoV-2 in corpses can vary among individuals and may be associated with the stage of the disease at the time of death. These important results complement many previously reported findings on the infectivity of SARS-CoV-2 at postmortem.